Comparison of the antidepressant effects of venlafaxine and dosulepin in a naturalistic setting

The relative efficacy of the various classes of antidepressants has not been established. Observational studies in naturalistic settings are important in evaluating treatment outcomes with antidepressants, since controlled clinical trials include only a minority of patients present in clinical pract...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Nordic journal of psychiatry 2009, Vol.63 (4), p.347-351
Hauptverfasser: Bukh, Jens Drachmann, Jørgensen, Martin Balslev, Dam, Henrik, Plenge, Per
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 351
container_issue 4
container_start_page 347
container_title Nordic journal of psychiatry
container_volume 63
creator Bukh, Jens Drachmann
Jørgensen, Martin Balslev
Dam, Henrik
Plenge, Per
description The relative efficacy of the various classes of antidepressants has not been established. Observational studies in naturalistic settings are important in evaluating treatment outcomes with antidepressants, since controlled clinical trials include only a minority of patients present in clinical practice. This study sought to evaluate in a naturalistic setting the treatment outcomes of dosulepin and venlafaxine for patients with depressive episodes. At the university hospital in Copenhagen, Denmark, between 1998 and early 2001, the first-line treatment for psychiatric inpatients with depression was dosulepin; after that time, venlafaxine was the first-line medication. We compared the treatment outcomes among inpatients during the respective periods. There was no significant difference in the primary outcome parameters between the two groups. A tendency in favour of dosulepin confirmed by a post-hoc analysis suggested that the failure to achieve significant difference was related to a type 2 error. However, missing data and possible confounders related to the different treatment periods weaken the results. This naturalistic study showed a non-significant trend for poorer treatment outcomes (probably because of an underpowered design) after replacing dosulepin with venlafaxine as first-line drug for depression in a naturalistic inpatient setting.
doi_str_mv 10.1080/08039480902799099
format Article
fullrecord <record><control><sourceid>pubmed_cross</sourceid><recordid>TN_cdi_pubmed_primary_19347769</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>19347769</sourcerecordid><originalsourceid>FETCH-LOGICAL-c380t-f93ed9661bdd73fdfbb2e1bbbeea4ea0e9a934365343d22bc5fa60b675c1b9fe3</originalsourceid><addsrcrecordid>eNp9UF1LwzAUDaK4Of0Bvkj_QDVp1nZBX2T4BQNf9LncNDcuo0tKkqr792ZsICIM7hfccw6HQ8glo9eMzuhNai6mMypoUQtBhTgiY1bSIp_WRXlMxtt_ngCzETkLYUUp5bwQp2TEBJ_WdSXGpJm7dQ_eBGczp7O4xAxsNAp7jyGkM0OtsY1h-_1E24GGb2O3KJUpF4YOe2OzVJBZiIOHzoRo2ixgjMZ-nJMTDV3Ai_2ekPfHh7f5c754fXqZ3y_yls9ozLXgqERVMalUzbXSUhbIpJSIMEWgKCBZ5lWZhioK2ZYaKiqrumyZFBr5hLCdbutdCB5103uzBr9pGG22YTX_wkqcqx2nH-Qa1S9jn04C3O0Axmrn1_DlfKeaCJvOee3BtiY0_JD-7R_6EqGLyxY8Nis3eJvyOODuB7l0jUE</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Comparison of the antidepressant effects of venlafaxine and dosulepin in a naturalistic setting</title><source>MEDLINE</source><source>Taylor &amp; Francis Medical Library - CRKN</source><source>Taylor &amp; Francis Journals Complete</source><creator>Bukh, Jens Drachmann ; Jørgensen, Martin Balslev ; Dam, Henrik ; Plenge, Per</creator><creatorcontrib>Bukh, Jens Drachmann ; Jørgensen, Martin Balslev ; Dam, Henrik ; Plenge, Per</creatorcontrib><description>The relative efficacy of the various classes of antidepressants has not been established. Observational studies in naturalistic settings are important in evaluating treatment outcomes with antidepressants, since controlled clinical trials include only a minority of patients present in clinical practice. This study sought to evaluate in a naturalistic setting the treatment outcomes of dosulepin and venlafaxine for patients with depressive episodes. At the university hospital in Copenhagen, Denmark, between 1998 and early 2001, the first-line treatment for psychiatric inpatients with depression was dosulepin; after that time, venlafaxine was the first-line medication. We compared the treatment outcomes among inpatients during the respective periods. There was no significant difference in the primary outcome parameters between the two groups. A tendency in favour of dosulepin confirmed by a post-hoc analysis suggested that the failure to achieve significant difference was related to a type 2 error. However, missing data and possible confounders related to the different treatment periods weaken the results. This naturalistic study showed a non-significant trend for poorer treatment outcomes (probably because of an underpowered design) after replacing dosulepin with venlafaxine as first-line drug for depression in a naturalistic inpatient setting.</description><identifier>ISSN: 0803-9488</identifier><identifier>EISSN: 1502-4725</identifier><identifier>DOI: 10.1080/08039480902799099</identifier><identifier>PMID: 19347769</identifier><language>eng</language><publisher>England: Informa UK Ltd</publisher><subject>Adult ; Antidepressants ; Antidepressive Agents, Second-Generation - adverse effects ; Antidepressive Agents, Second-Generation - pharmacokinetics ; Antidepressive Agents, Second-Generation - therapeutic use ; Antidepressive Agents, Tricyclic - adverse effects ; Antidepressive Agents, Tricyclic - pharmacokinetics ; Antidepressive Agents, Tricyclic - therapeutic use ; Cyclohexanols - adverse effects ; Cyclohexanols - pharmacokinetics ; Cyclohexanols - therapeutic use ; Denmark ; Depressive Disorder, Major - blood ; Depressive Disorder, Major - diagnosis ; Depressive Disorder, Major - drug therapy ; Dosulepin ; Dothiepin - adverse effects ; Dothiepin - pharmacokinetics ; Dothiepin - therapeutic use ; Drug Therapy, Combination ; Effectiveness ; Female ; Humans ; Length of Stay ; Male ; Middle Aged ; Naturalistic ; Retrospective Studies ; Treatment Outcome ; Venlafaxine ; Venlafaxine Hydrochloride</subject><ispartof>Nordic journal of psychiatry, 2009, Vol.63 (4), p.347-351</ispartof><rights>2009 Informa UK Ltd All rights reserved: reproduction in whole or part not permitted 2009</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c380t-f93ed9661bdd73fdfbb2e1bbbeea4ea0e9a934365343d22bc5fa60b675c1b9fe3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.tandfonline.com/doi/pdf/10.1080/08039480902799099$$EPDF$$P50$$Ginformaworld$$H</linktopdf><linktohtml>$$Uhttps://www.tandfonline.com/doi/full/10.1080/08039480902799099$$EHTML$$P50$$Ginformaworld$$H</linktohtml><link.rule.ids>314,780,784,4021,27921,27922,27923,59645,59751,60434,60540,61219,61254,61400,61435</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19347769$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Bukh, Jens Drachmann</creatorcontrib><creatorcontrib>Jørgensen, Martin Balslev</creatorcontrib><creatorcontrib>Dam, Henrik</creatorcontrib><creatorcontrib>Plenge, Per</creatorcontrib><title>Comparison of the antidepressant effects of venlafaxine and dosulepin in a naturalistic setting</title><title>Nordic journal of psychiatry</title><addtitle>Nord J Psychiatry</addtitle><description>The relative efficacy of the various classes of antidepressants has not been established. Observational studies in naturalistic settings are important in evaluating treatment outcomes with antidepressants, since controlled clinical trials include only a minority of patients present in clinical practice. This study sought to evaluate in a naturalistic setting the treatment outcomes of dosulepin and venlafaxine for patients with depressive episodes. At the university hospital in Copenhagen, Denmark, between 1998 and early 2001, the first-line treatment for psychiatric inpatients with depression was dosulepin; after that time, venlafaxine was the first-line medication. We compared the treatment outcomes among inpatients during the respective periods. There was no significant difference in the primary outcome parameters between the two groups. A tendency in favour of dosulepin confirmed by a post-hoc analysis suggested that the failure to achieve significant difference was related to a type 2 error. However, missing data and possible confounders related to the different treatment periods weaken the results. This naturalistic study showed a non-significant trend for poorer treatment outcomes (probably because of an underpowered design) after replacing dosulepin with venlafaxine as first-line drug for depression in a naturalistic inpatient setting.</description><subject>Adult</subject><subject>Antidepressants</subject><subject>Antidepressive Agents, Second-Generation - adverse effects</subject><subject>Antidepressive Agents, Second-Generation - pharmacokinetics</subject><subject>Antidepressive Agents, Second-Generation - therapeutic use</subject><subject>Antidepressive Agents, Tricyclic - adverse effects</subject><subject>Antidepressive Agents, Tricyclic - pharmacokinetics</subject><subject>Antidepressive Agents, Tricyclic - therapeutic use</subject><subject>Cyclohexanols - adverse effects</subject><subject>Cyclohexanols - pharmacokinetics</subject><subject>Cyclohexanols - therapeutic use</subject><subject>Denmark</subject><subject>Depressive Disorder, Major - blood</subject><subject>Depressive Disorder, Major - diagnosis</subject><subject>Depressive Disorder, Major - drug therapy</subject><subject>Dosulepin</subject><subject>Dothiepin - adverse effects</subject><subject>Dothiepin - pharmacokinetics</subject><subject>Dothiepin - therapeutic use</subject><subject>Drug Therapy, Combination</subject><subject>Effectiveness</subject><subject>Female</subject><subject>Humans</subject><subject>Length of Stay</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Naturalistic</subject><subject>Retrospective Studies</subject><subject>Treatment Outcome</subject><subject>Venlafaxine</subject><subject>Venlafaxine Hydrochloride</subject><issn>0803-9488</issn><issn>1502-4725</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9UF1LwzAUDaK4Of0Bvkj_QDVp1nZBX2T4BQNf9LncNDcuo0tKkqr792ZsICIM7hfccw6HQ8glo9eMzuhNai6mMypoUQtBhTgiY1bSIp_WRXlMxtt_ngCzETkLYUUp5bwQp2TEBJ_WdSXGpJm7dQ_eBGczp7O4xAxsNAp7jyGkM0OtsY1h-_1E24GGb2O3KJUpF4YOe2OzVJBZiIOHzoRo2ixgjMZ-nJMTDV3Ai_2ekPfHh7f5c754fXqZ3y_yls9ozLXgqERVMalUzbXSUhbIpJSIMEWgKCBZ5lWZhioK2ZYaKiqrumyZFBr5hLCdbutdCB5103uzBr9pGG22YTX_wkqcqx2nH-Qa1S9jn04C3O0Axmrn1_DlfKeaCJvOee3BtiY0_JD-7R_6EqGLyxY8Nis3eJvyOODuB7l0jUE</recordid><startdate>2009</startdate><enddate>2009</enddate><creator>Bukh, Jens Drachmann</creator><creator>Jørgensen, Martin Balslev</creator><creator>Dam, Henrik</creator><creator>Plenge, Per</creator><general>Informa UK Ltd</general><general>Taylor &amp; Francis</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>2009</creationdate><title>Comparison of the antidepressant effects of venlafaxine and dosulepin in a naturalistic setting</title><author>Bukh, Jens Drachmann ; Jørgensen, Martin Balslev ; Dam, Henrik ; Plenge, Per</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c380t-f93ed9661bdd73fdfbb2e1bbbeea4ea0e9a934365343d22bc5fa60b675c1b9fe3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2009</creationdate><topic>Adult</topic><topic>Antidepressants</topic><topic>Antidepressive Agents, Second-Generation - adverse effects</topic><topic>Antidepressive Agents, Second-Generation - pharmacokinetics</topic><topic>Antidepressive Agents, Second-Generation - therapeutic use</topic><topic>Antidepressive Agents, Tricyclic - adverse effects</topic><topic>Antidepressive Agents, Tricyclic - pharmacokinetics</topic><topic>Antidepressive Agents, Tricyclic - therapeutic use</topic><topic>Cyclohexanols - adverse effects</topic><topic>Cyclohexanols - pharmacokinetics</topic><topic>Cyclohexanols - therapeutic use</topic><topic>Denmark</topic><topic>Depressive Disorder, Major - blood</topic><topic>Depressive Disorder, Major - diagnosis</topic><topic>Depressive Disorder, Major - drug therapy</topic><topic>Dosulepin</topic><topic>Dothiepin - adverse effects</topic><topic>Dothiepin - pharmacokinetics</topic><topic>Dothiepin - therapeutic use</topic><topic>Drug Therapy, Combination</topic><topic>Effectiveness</topic><topic>Female</topic><topic>Humans</topic><topic>Length of Stay</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Naturalistic</topic><topic>Retrospective Studies</topic><topic>Treatment Outcome</topic><topic>Venlafaxine</topic><topic>Venlafaxine Hydrochloride</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bukh, Jens Drachmann</creatorcontrib><creatorcontrib>Jørgensen, Martin Balslev</creatorcontrib><creatorcontrib>Dam, Henrik</creatorcontrib><creatorcontrib>Plenge, Per</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><jtitle>Nordic journal of psychiatry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bukh, Jens Drachmann</au><au>Jørgensen, Martin Balslev</au><au>Dam, Henrik</au><au>Plenge, Per</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Comparison of the antidepressant effects of venlafaxine and dosulepin in a naturalistic setting</atitle><jtitle>Nordic journal of psychiatry</jtitle><addtitle>Nord J Psychiatry</addtitle><date>2009</date><risdate>2009</risdate><volume>63</volume><issue>4</issue><spage>347</spage><epage>351</epage><pages>347-351</pages><issn>0803-9488</issn><eissn>1502-4725</eissn><abstract>The relative efficacy of the various classes of antidepressants has not been established. Observational studies in naturalistic settings are important in evaluating treatment outcomes with antidepressants, since controlled clinical trials include only a minority of patients present in clinical practice. This study sought to evaluate in a naturalistic setting the treatment outcomes of dosulepin and venlafaxine for patients with depressive episodes. At the university hospital in Copenhagen, Denmark, between 1998 and early 2001, the first-line treatment for psychiatric inpatients with depression was dosulepin; after that time, venlafaxine was the first-line medication. We compared the treatment outcomes among inpatients during the respective periods. There was no significant difference in the primary outcome parameters between the two groups. A tendency in favour of dosulepin confirmed by a post-hoc analysis suggested that the failure to achieve significant difference was related to a type 2 error. However, missing data and possible confounders related to the different treatment periods weaken the results. This naturalistic study showed a non-significant trend for poorer treatment outcomes (probably because of an underpowered design) after replacing dosulepin with venlafaxine as first-line drug for depression in a naturalistic inpatient setting.</abstract><cop>England</cop><pub>Informa UK Ltd</pub><pmid>19347769</pmid><doi>10.1080/08039480902799099</doi><tpages>5</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0803-9488
ispartof Nordic journal of psychiatry, 2009, Vol.63 (4), p.347-351
issn 0803-9488
1502-4725
language eng
recordid cdi_pubmed_primary_19347769
source MEDLINE; Taylor & Francis Medical Library - CRKN; Taylor & Francis Journals Complete
subjects Adult
Antidepressants
Antidepressive Agents, Second-Generation - adverse effects
Antidepressive Agents, Second-Generation - pharmacokinetics
Antidepressive Agents, Second-Generation - therapeutic use
Antidepressive Agents, Tricyclic - adverse effects
Antidepressive Agents, Tricyclic - pharmacokinetics
Antidepressive Agents, Tricyclic - therapeutic use
Cyclohexanols - adverse effects
Cyclohexanols - pharmacokinetics
Cyclohexanols - therapeutic use
Denmark
Depressive Disorder, Major - blood
Depressive Disorder, Major - diagnosis
Depressive Disorder, Major - drug therapy
Dosulepin
Dothiepin - adverse effects
Dothiepin - pharmacokinetics
Dothiepin - therapeutic use
Drug Therapy, Combination
Effectiveness
Female
Humans
Length of Stay
Male
Middle Aged
Naturalistic
Retrospective Studies
Treatment Outcome
Venlafaxine
Venlafaxine Hydrochloride
title Comparison of the antidepressant effects of venlafaxine and dosulepin in a naturalistic setting
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-14T05%3A42%3A08IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Comparison%20of%20the%20antidepressant%20effects%20of%20venlafaxine%20and%20dosulepin%20in%20a%20naturalistic%20setting&rft.jtitle=Nordic%20journal%20of%20psychiatry&rft.au=Bukh,%20Jens%20Drachmann&rft.date=2009&rft.volume=63&rft.issue=4&rft.spage=347&rft.epage=351&rft.pages=347-351&rft.issn=0803-9488&rft.eissn=1502-4725&rft_id=info:doi/10.1080/08039480902799099&rft_dat=%3Cpubmed_cross%3E19347769%3C/pubmed_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/19347769&rfr_iscdi=true